Century Therapeutics Faces Market Volatility Amid Ongoing Cell Therapy Research
Century Therapeutics, a biotech company focused on adult stem cells for cancer treatment, has experienced market volatility and a decline in stock price, but continues to focus on developing innovative cell therapy products.
2 minutes to read